Dividends CalendarEarnings Calendar
ATNX

ATNX | Athenex Inc

Athenex Inc
Category: Consumer goods
  • Industry: Healthcare

Quick infos

  • Headquarters:   Buffalo, New York, United States

Trade prices

  • Volume:
  • Market Cap: 1.16B
  • Prev closed: 11.5
  • Open: 11.42
  • High: 12.4
  • Low: 11.39
  • 52 week low: 5.63
  • 52 week high: 15.67
  • Dividends:No Dividends

Next ER: November 5, 2020 



Top Stories (ATNX)

    Company Profile

    Athenex is a global oncology focused biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, aiming to develop safer and more efficacious cancer medication. Founded in 2003 and based in Buffalo, New York, our mission is to improve the lives of cancer patients by creating more effective, safer and tolerable treatments. Our current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) T-cell receptor-engineered T-cells (TCR-T), and (4) Arginine deprivation therapy. We currently have nine clinical assets including two drug candidates with completed Phase 3 pivotal studies. Athenex?s employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 13, 2021
    March 29, 2021
    November 5, 2020-0.4 / -0.47535.48M / 17.95MBeat!
    August 6, 2020-0.5 / -0.4240.17M / 25.46MBeat!
    May 7, 2020-0.24 / -0.1646.94M / 35.69MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jan 22, 2021 12.38 11.53
    12.39
    11.49
    881.87K 7.65%
    Jan 21, 2021 11.50 11.53
    11.62
    11.29
    437.94K 0.70%
    Jan 20, 2021 11.42 11.20
    11.59
    11.18
    371.10K 1.60%
    Jan 19, 2021 11.24 11.32
    11.50
    11.06
    645.26K 1.17%
    Jan 15, 2021 11.11 11.60
    11.63
    11.07
    475.89K -4.72%
    Jan 14, 2021 11.66 10.95
    11.85
    10.86
    923.66K 9.18%
    Jan 13, 2021 10.68 11.26
    11.26
    10.60
    1.33M -4.64%
    Jan 12, 2021 11.20 11.30
    11.33
    11.10
    588.56K 0.63%
    Jan 11, 2021 11.13 11.78
    11.80
    11.10
    805.62K -4.46%
    Jan 8, 2021 11.65 12.03
    12.18
    11.32
    997.76K -3.64%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2003
    • Employees:575

    News

    News for (ATNX)

    This company doesn't provide a dividend.

    Key Persons

    • CFO :  Randoll Sze

    Talk about Athenex Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 5, 2020 (Same day)

    clls glp cron core xray evrg bldp adt xxii trxc atnx 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet